SAN JOSE, Calif., April 02, 2018 -- According to the latest report published by Credence Research, Inc. “Organ on Chip Market - Growth, Future Prospects and Competitive Analysis, 2018-2026,” the global organ on chip market is expected to witness significant growth.
Market Insights
Direct recognition and investigation of biomolecules and cells in physiological microenvironment is essential for quick assessment of pharmacy and biology. The past several years have seen surprising improvements in the development of in vitro organs and tissues model with various purposes based on microfluidic devices known as organ on chip.
Organ on chip technology aims at creating imitation active organs that mimic the complex and biological reactions of actual organs, keeping in mind the goal to examine drugs’ action by exactly manipulating the cells and their microenvironments. To accomplish this, the artificial organs ought to be micro fabricated with an extracellular matrix (ECM) and different sorts of cells, and recapitulate morphogenesis, cell differentiation, and functions corresponding the local organ.
Based on the product types, the global organ on chip market is segmented into lungs on chip, heart on chip, liver on chip, kidney on chip, and others; additionally the end users studied in this report are categorized into research institutes, and pharmaceutical manufacturers. Advancement in technology of organ on chip is capable of accelerating the speed of drug testing, producing more reliable data, and dropping the financial and ethical drawbacks of preclinical research will boost the market of organ on chip.
Geographically, the overall organ on chip market is projected for Middle East and Africa, Europe, Latin America, Asia Pacific, and North America. As for revenue share, North America leads the global market and is expected that the situation will remain consistent amid the forecast period. Though the control of North America on the global market will be clearly challenged by Asia Pacific. The need of organ on chip has become prominent in Asia Pacific because of growth in the healthcare infrastructure, healthcare expenditure, and flexible income. There are massive chances for market diffusion in nations like India, Mexico, and China to the market occupants already having a grip in developed countries.
Browse Full Report With TOC, Figures And Tables @ http://www.credenceresearch.com/report/organ-on-chip-market
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
E-mail: [email protected]
Ph: +1-800-361-8290
Connect With US:
Web: Credence Research
Facebook @ https://www.facebook.com/CredenceResearch
Twitter @ https://twitter.com/CredenceResearc
Linkedin @ https://us.linkedin.com/company/credenceresearch
G+ @ https://plus.google.com/+Credenceresearch
Our Blog: http://globalpharmaindustry.com/


Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
Jetstar to Charge for Overhead Cabin Bags From February
Capital One Says AML Review Led to Closure of Trump Organization Accounts
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover
Apple Restores Telegram to App Store After Content Policy Violation
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring 



